Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 42 articles: HTML format

Single Articles

August 2023
1. SACHER A, LoRusso P, Patel MR, Miller WH Jr, et al
   Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
   N Engl J Med. 2023;389:710-721.
   PubMed     Abstract available
   
   
   July 2023
2. DOSSA F, Baxter NN
   Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.
   N Engl J Med. 2023;389:375-377.
   PubMed    
   
   
   
3. SCHRAG D, Shi Q, Weiser MR, Gollub MJ, et al
   Preoperative Treatment of Locally Advanced Rectal Cancer.
   N Engl J Med. 2023;389:322-334.
   PubMed     Abstract available
   
   
   
4. TABERNERO J, Fakih M, Prager GW
   Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
   N Engl J Med. 2023;389:190-191.
   PubMed    
   
   
   
5. VAN DE HAAR J, Valeri N, Voest EE
   Third-Line Therapy in Metastatic Colorectal Cancer.
   N Engl J Med. 2023;389:190.
   PubMed    
   
   
   May 2023
6. YEKU OO, Longo DL
   Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer.
   N Engl J Med. 2023;388:1711-1714.
   PubMed    
   
   
   
7. PRAGER GW, Taieb J, Fakih M, Ciardiello F, et al
   Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
   N Engl J Med. 2023;388:1657-1667.
   PubMed     Abstract available
   
   
   March 2023
8. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
   Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
   N Engl J Med. 2023;388:824-832.
   PubMed     Abstract available
   
   
   January 2023
9. DOMINITZ JA, Robertson DJ
   Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
   N Engl J Med. 2023;388:379.
   PubMed    
   
   
   
10. BRETTHAUER M, Loberg M, Kaminski MF
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:378-379.
    PubMed    
    
    
    
11. CAPPELL MS, Tobi M, Yang YX
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:378.
    PubMed    
    
    
    
12. HOFFMEISTER M, Cardoso R, Brenner H
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377-378.
    PubMed    
    
    
    
13. WINAWER SJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377.
    PubMed    
    
    
    
14. DECK W
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376-377.
    PubMed    
    
    
    
15. HANLEY JA
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376.
    PubMed    
    
    
    December 2022
16. YAEGER R, Weiss J, Pelster MS, Spira AI, et al
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
    PubMed     Abstract available
    
    
    November 2022
17. PAPKE DJ JR, Yurgelun MB, Noffsinger AE, Turner KO, et al
    Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
    N Engl J Med. 2022;387:1714-1716.
    PubMed    
    
    
    October 2022
18. DOMINITZ JA, Robertson DJ
    Understanding the Results of a Randomized Trial of Screening Colonoscopy.
    N Engl J Med. 2022;387:1609-1611.
    PubMed    
    
    
    
19. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    PubMed     Abstract available
    
    
    September 2022
20. CERCEK A, Diaz LA Jr
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer. Reply.
    N Engl J Med. 2022;387:855-856.
    PubMed    
    
    
    
21. GANGULY S, Gogia A
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:855.
    PubMed    
    
    
    
22. COPUR MS, Tun SM, Duckert R
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:854-855.
    PubMed    
    
    
    August 2022
23. TIE J, Lo SN, Gibbs P
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply.
    N Engl J Med. 2022;387:760.
    PubMed    
    
    
    
24. OTSUKA M
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759-760.
    PubMed    
    
    
    
25. HINDIE E
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759.
    PubMed    
    
    
    
26. PALEFSKY JM, Lee JY
    Prevention of Anal Cancer. Reply.
    N Engl J Med. 2022;387:666-667.
    PubMed    
    
    
    
27. REVOLLO B, Videla S, Llibre JM
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:666.
    PubMed    
    
    
    
28. KREUTER A, Wieland U
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665-666.
    PubMed    
    
    
    
29. GOFFREDO P, Klemen ND, Hassan I
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665.
    PubMed    
    
    
    July 2022
30. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    PubMed    
    
    
    
31. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    PubMed    
    
    
    
32. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    PubMed    
    
    
    June 2022
33. SANOFF HK
    Improving Treatment Approaches for Rectal Cancer.
    N Engl J Med. 2022;386:2425-2426.
    PubMed    
    
    
    
34. CERCEK A, Lumish M, Sinopoli J, Weiss J, et al
    PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    N Engl J Med. 2022;386:2363-2376.
    PubMed     Abstract available
    
    
    
35. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available
    
    
    
36. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    PubMed    
    
    
    
37. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    PubMed     Abstract available
    
    
    
38. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.
    PubMed    
    
    
    April 2022
39. SINICROPE FA
    Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;386:1547-1558.
    PubMed    
    
    
    February 2022
40. DOUBENI CA, Corley DA, Zhao W, Lau Y, et al
    Association between Improved Colorectal Screening and Racial Disparities.
    N Engl J Med. 2022;386:796-798.
    PubMed    
    
    
    
41. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    
    
    
    January 2022
42. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: